Recent Price Movement and Market Context
On 17 Mar 2026, Evexia Lifecare’s share price declined by 4.27% on the day, underperforming the edible oil sector by 3.34%. This marks the third consecutive day of losses, during which the stock has fallen by 22.07%. The current price of Rs.1.12 is substantially lower than its 52-week high of Rs.3.04, representing a steep decline over the past year.
The broader market, represented by the Sensex, has shown resilience, opening 323.83 points higher and trading at 75,877.60, up 0.5%. However, the Sensex itself is trading below its 50-day moving average, which in turn is below the 200-day moving average, signalling a cautious market environment. Mega-cap stocks are leading the gains, while micro-cap stocks like Evexia Lifecare continue to face headwinds.
Technical Indicators Reflect Bearish Sentiment
Evexia Lifecare is trading below all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – indicating a sustained downtrend. Technical momentum indicators provide a mixed picture: the MACD is bearish on both weekly and monthly charts, while the Bollinger Bands also signal bearishness. The Relative Strength Index (RSI) shows a weekly bullish signal but no monthly indication, suggesting short-term oversold conditions amid longer-term weakness. The KST indicator is mildly bullish weekly but bearish monthly, and Dow Theory assessments are mildly bearish across weekly and monthly timeframes.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Financial Performance and Fundamental Assessment
Evexia Lifecare’s financial metrics reveal persistent challenges. The company has experienced a compound annual growth rate (CAGR) decline of 23.63% in operating profits over the last five years, indicating a weakening earnings base. Over the past year, profits have fallen by 60.3%, a steep contraction that has contributed to the stock’s negative returns of 56.42% during the same period.
Return on Equity (ROE) averages a modest 0.88%, reflecting limited profitability relative to shareholders’ funds. The Return on Capital Employed (ROCE) stands at 0.1, which is low but accompanied by an attractive valuation metric: an Enterprise Value to Capital Employed ratio of 0.8. This suggests that while profitability is subdued, the stock is trading at a discount compared to its peers’ historical valuations.
The company’s ability to service debt is constrained, with a Debt to EBITDA ratio of -1.00 times, signalling a high leverage position relative to earnings before interest, taxes, depreciation, and amortisation. This financial structure may limit flexibility in capital allocation and growth initiatives.
Long-Term and Recent Performance Trends
Evexia Lifecare’s stock has underperformed not only in the past year but also over longer horizons. It has lagged the BSE500 index across three years, one year, and three months, underscoring persistent relative weakness. The stock’s micro-cap status further accentuates its volatility and sensitivity to market fluctuations.
Majority shareholding remains with non-institutional investors, which may influence liquidity and trading patterns. The flat financial results reported in December 2025 add to the subdued sentiment surrounding the company’s near-term prospects.
Evexia Lifecare Ltd or something better? Our SwitchER feature analyzes this micro-cap Edible Oil stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Market Capitalisation and Rating Overview
Evexia Lifecare is classified as a micro-cap stock, reflecting its relatively small market capitalisation. The company’s Mojo Score stands at 23.0, with a recent downgrade in Mojo Grade from Sell to Strong Sell as of 28 Apr 2025. This rating reflects the deteriorated fundamental strength and weak financial metrics that have influenced the stock’s performance and outlook.
Despite the current valuation discount, the combination of weak profitability, high leverage, and sustained price declines has contributed to the cautious stance reflected in the rating.
Summary of Key Technical and Fundamental Factors
Evexia Lifecare’s stock is characterised by a downward price trajectory, confirmed by its position below all major moving averages and bearish technical indicators. The company’s financial profile shows declining profits, low returns on equity and capital, and a challenging debt position. While valuation metrics suggest the stock trades at a discount relative to peers, the overall performance trend remains subdued.
The broader market environment, with mega-cap stocks leading gains and the Sensex trading below key moving averages, adds context to the stock’s performance within the edible oil sector and micro-cap segment.
Conclusion
Evexia Lifecare Ltd’s fall to a new 52-week low of Rs.1.12 highlights the ongoing pressures faced by the company in terms of profitability, leverage, and market sentiment. The stock’s underperformance relative to sector peers and broader indices reflects a combination of financial and technical factors that have weighed on investor confidence. While the valuation appears attractive on certain metrics, the company’s financial results and rating downgrade underscore the challenges it continues to face.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
